Potential role of calmodulin-dependent phosphodiesterase in human brain tumor (review)

Oncology Reports

Volumn 14, Issue 4, 2005, Pages 1059-1063

  Das, Shankar B ^a   Sharma, Rajendra K ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Brain tumor; Glioblastoma multiforme; Immunohistochemistry; Inhibitor protein; Phosphodiesterase

Indexed keywords

3',5' CYCLIC NUCLEOTIDE PHOSPHODIESTERASE;

BRAIN TUMOR; DOSE RESPONSE; ENZYMOLOGY; GLIOBLASTOMA; HUMAN; METABOLISM; PATHOLOGY; PHYSIOLOGY; REVIEW; TISSUE DISTRIBUTION; TUMOR CELL LINE; WESTERN BLOTTING;

3',5'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; BLOTTING, WESTERN; BRAIN NEOPLASMS; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; GLIOBLASTOMA; HUMANS; TISSUE DISTRIBUTION;

EID: 33644821246     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.14.4.1059     Document Type: Review

References (43)

1. Black KL and Ningaraj NS: Modulation of brain tumor capillaries for enhanced drug delivery selectively to brain tumor. Cancer Control 11: 165-173, 2004. (Pubitemid 38758221)
2. Smith MA, Freidlin B, Ries LA and Simon R: Trends in reported incidence of primary malignant brain tumors in children in the United States. J Natl Cancer Inst 90: 1269-1277, 1998. (Pubitemid 28433471)
3. Baldwin RT and Preston-Martin S: Epidemiology of brain tumors in childhood - a review. Toxicol Appl Pharmacol 199: 118-131, 2004. (Pubitemid 39094530)
4. Beavo JA, Conti M and Heaslip RJ: Multiple cyclic nucleotide phosphodiesterases. Mol Pharmacol 46: 399-405, 1994. (Pubitemid 24296671)
5. Kakkar R, Raju RVS and Sharma RK: Calmodulin-dependent cyclic nucleotide phosphodiesterase (PDE1). Cell Mol Life Sci 55: 1164-1186, 1999. (Pubitemid 29361080)
6. Sharma RK: Diversity of calcium actions in regulation of calmodulin-dependent cyclic nucleotide phosphodiesterase. Indian J Biochem Biophys 40: 77-91, 2003.
7. Sharma RK, Adachi AM Adachi K and Wang JH: Demonstration of bovine brain calmodulin-dependent cyclic nucleotide phosphosiesterase isozymes by monoclonal antibodies. J Biol Chem 259: 9248-9254, 1984. (Pubitemid 14098913)
8. Epstein PM and Hachisu R: Cyclic nucleotide phosphodiesterase of normal and leukemic lymphocytes and lymphoblasts. Adv Cyclic Nucleotide Protein Phosphorylation Res 16: 303-324, 1984.
9. Onali P, Strada SJ, Chang L, Epstein PM, Hersh EM and Thompson WJ: Purification and characterization of high-affinity cyclic adenosine 5′-monophosphate phosphodiesterases from human acute myelogenous leukemic cells. Cancer Res 45: 1384-1391, 1985. (Pubitemid 15111308)
10. Aleksijevic A, Lugnier C, Giron C, Mayer S, Stoclet JC and Lang JM: Cyclic AMP and cyclic GMP phosphodiesterase activities in Hodgkin's disease lymphocytes. Int J Immunopharmacol 9: 525-531, 1987. (Pubitemid 17101937)
11. Wei J-W and Hickie RA: Decreased activities of cyclic adenosine 3′:5′-monophosphate phosphodiesterases in Morris hepatomas having varying growth rates. Int J Biochem 15: 789-795, 1983.
12. Turnbull JL and Hickie RA: The isolation and characterization of cyclic nucleotide phosphodiesterases from Morris hepatoma 5123 t.c. (h) and rat liver. Int J Biochem 16: 19-29, 1984. (Pubitemid 14153531)
13. Kumar S, Becker G and Prasad KN: Cyclic adenosine 3′:5′- monophosphate phosphodiesterase activity in malignant and cyclic adenosine 3′:5′-monophosphate-induced 'differentiated' neuroblastoma cells. Cancer Res 35: 82-87, 1975.
14. Singer AL, Sherwin RP, Dunn AS and Appleman MM: Cyclic nucleotide phosphodiesterases in neoplastic and non-neoplastic human mammary tissues. Cancer Res 36: 60-66, 1976.
15. Hickie RA, Thompson WJ, Strada SJ, Couture-Murillo B, Morris HP and Robinson GA: Comaprison of cyclic adenosine 3′:5′-monophosphate and cyclic gaunosine 3′:5′-monophosphate levels, cyclases, and phosphodiesterases in Morris hepatomas and liver. Cancer Res 37: 3599-3606, 1977. (Pubitemid 8198419)
16. Whitfield JF, Boynton AL, MacManus JP, Sikorska M and Tsang BK: The regulation of cell proliferation by calcium and cyclic AMP. Mol Cell Biochem 27: 155-179, 1979. (Pubitemid 10218207)
17. Thompson WJ, Ross CP, Strada SJ, Hersh EM and Lavis VR: Comparative analysis of cyclic adenosine 3′:5′-monophosphate phosphodiesterase of human peripheral blood monocytes and cultured P388D1 cells. Cancer Res 40: 1955-1960, 1980. (Pubitemid 10116120)
18. Stefanovich V, Ambrus J, Karakousis C and Takita H: Cyclic nucleotide phosphodiesterases in normal and malignant human tissues. J Med 12: 243-250, 1981. (Pubitemid 11027821)
19. Hickie RA, Graham MJ, Buckmeier JA and Meyskens FL Jr: Comparison of calmodulin gene expression in human neonatal melanocytes and metastatic melanoma cell lines. J Invest Dermatol 99: 764-773, 1992. (Pubitemid 23002039)
20. Rybalkin SD, Bornfeldt KE, Sonnenberg WK, Rybalkina JG, Kwak KS and Hanson K: Calmodulin-stimulated cyclic phosphodiesterase (PDE1C) is induced in human arterial smooth muscle cells of the synthetic, proliferative phenotype. J Clin Invest 100: 2611-2621, 1997. (Pubitemid 27514902)
21. Beavo JA: Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms. Physiol Rev 75: 725-743, 1995.
22. Brostrom C and Wolf D: Calcium-dependent cyclic nucleotide phosphodiesterase from glial tumor cells. Arch Biochem Biophys 65: 715-727, 1974.
23. Lal S, Raju RVS, Macauley RJB and Sharma RK: Calmodulin-dependent cyclic nucleotide phospdiesterase in human cerebral cortex and glioblastoma multiforme. Can J Neurol Sci 23: 245-250, 1996. (Pubitemid 26403102)
24. Lai S, Sharma RK, McGregor C and Macaulay R: Immunohistochemical localization of calmodulin-dependent cyclic phosphodiesterase in the human brain. Neurochem Res 24: 43-49, 1999. (Pubitemid 29067775)
25. Gerfen CR, Engber TM, Mahan LC, Susel Z, Chase TN, Monsma FJ Jr and Sibley DR: D1 and D2 dopamine receptor-regulated gene expression of striatonigral striatopallidal neurons. Science 250: 1429-1432, 1990. (Pubitemid 120031867)
26. Weiner DM, Levey AI and Brann MR: Expression of muscarinic acetylcholine and dopamine receptor mRNAs in rat basal ganglia. Proc Natl Acad Sci USA 87: 7050-7054, 1990.
27. Weiner DM, Levey AI, Sunahara RK, Niznik HB, O'Dowd BF, Seeman P and Brann MR: D1 and D2 dopamine receptor mRNA in rat brain. Proc Natl Acad Sci USA 88: 1859-1863, 1991. (Pubitemid 21916326)
28. Surmeier DJ, Eberwine J, Wilson CJ, Cao Y, Stefani A and Kitai ST: Dopamine receptor subtypes colocalize in rat striatonigral neurons. Proc Natl Acad Sci USA 89: 10178-10182, 1992.
29. Polli JW and Kincaid RL: Expression of a calmodulin-dependent phosphodiesterase isoform (PDE1B1) correlates with brain regions having extensive dopaminergic innervation. J Neurosci 14: 1251-1261, 1994.
30. Cho-Chung YS: Role of cyclic AMP receptor proteins in growth, differentiation and suppression of malignancy: new approaches to therapy. Cancer Res 50: 7093-7100, 1971.
31. Nagamine Y and Reich E: Gene expression and cAMP. Proc Natl Acad Sci USA 82: 4606-4610, 1985. (Pubitemid 16239612)
32. Greengard P: Neuronal phosphoproteins. Mediators of signal transduction. Mol Neurobiol 1: 81-119, 1987.
33. Whitfield JF: Calcium signals and cancer. Crit Rev Oncog 3: 55-90, 1992.
34. Dousa TP: Cyclic-3′:5′-nucleotide phosphodiesterase isozymes in cell biology and pathophysiology of the kidney. Kidney Intl 55: 29-62, 1999.
35. Lai S, Raju RVS and Sharma RK: Novel protein inhibitor of calmodulin-dependent cyclic nucleotide phosphodiesterase from glioblastoma multiforme. Neurochem Res 23: 533-538, 1998. (Pubitemid 28177618)
36. Schuller H: The signal transduction model of carcinognenesis Biochem Pharmacol 42: 1511-1523, 1991.
37. Yuan X, Curtin J, Xiong Y, Liu G, Waschsmann-Hogiu S, Farkas DL, Black KL and Yu JS: Isolation of cancer stem cells from adult glioblastoma multiforme. Oncogene 23: 9392-9400, 2004. (Pubitemid 40069671)
38. Lapidot T, Sirard C, Vormoor J, Murdoch B, Hoang T, Caceres-Cortes J, Minden M, Pareson B, Caligiuri MA and Dick JE: A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 367: 645-648, 1994. (Pubitemid 24067706)
39. Al-Hajj M, Becker MW, Wicha M, Weissman I and Clarke MF: Therapeutic implications of cancer stem cells. Curr Opin Genet Dev 14: 43-47, 2004. (Pubitemid 38167476)
40. Dick JE: Breast cancer stem cells revealed. Proc Natl Acad Sci USA 100: 3547-3549, 2003.
41. Singh SK, Clarke ID, Tersaki M, Bonn VE, Hawkins C, Squire J and Dirks PB: Identification of a cancer stem cell in human brain tumors. Cancer Res 63: 5821-5828, 2003. (Pubitemid 37187480)
42. Kondo T, Setoguchi T and Taga T: Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line Proc Natl Acad Sci USA 101: 781-786, 2004. (Pubitemid 38121035)
43. Matsumoto T, Kobayashi T and Kamata K: Phosphodiesterases in the vascular system. J Smooth Muscle Res 39: 67-86, 2003. (Pubitemid 38017646)